The Rising Prevalence of Pediatric Hypertension

Published Online: Thursday, August 16, 2012
Follow Pharmacy_Times:
Pediatric hypertension-related hospitalizations in the United States have nearly doubled, from 12,661 in 1997 to 24,602 in 2006, according to a new study published in the American Heart Association journal Hypertension.

For the study, researchers analyzed records from the Healthcare Cost and Utilization Project Kids’ Inpatient Database from 1997, 2000, 2003, and 2006 to evaluate the health care utilization of hospitalized children with hypertension.

Cheryl Tran, MD, of CS Mott Children’s Hospital, and colleagues found that both the frequency and charges for pediatric hypertension–associated hospitalizations increased from 1997 to 2006. The total charges for hypertensionassociated hospitalizations were an estimated $3.1 billion, with mean hospitalization charges increasing by 50%.

The researchers also found a higher frequency of hypertension discharges in children aged 10 to 18 years compared with kids aged 2 to 9 years. They speculate that the higher prevalence of hypertension seen in the older group of children is a result of the rise in adolescent obesity throughout the 10-year study period.

In an accompanying editorial, Joshua Samuels, MD, noted that the study dispels the myth that hypertension is an adult disease with no real relevance to pediatric populations.

To read more articles in this watch, click:
Insomnia Raises Risk of Developing High Blood Pressure
Hidden Hypertensive Heart Disease Ubiquitous in African Americans


Related Articles
The Pharmacy Quality Alliance (PQA) has retired a performance measure on treating hypertension in patients with diabetes that is no longer in accordance with the Joint National Committee’s (JNC8) 2014 hypertension guidelines.
Results of a peer-reviewed clinical study support the use of pharmacy-based PharmaSmart kiosks in assessing hypertension, as the routine blood pressure testing on the kiosks was deemed comparable to daytime ambulatory blood pressure measurement.
Mylan and Teva have separately announced the US launches of their respective valsartan tablets, the generic version of Novartis’ antihypertensive agent, Diovan.
Joseph Saseen, PharmD, from the Department of Clinical Pharmacy at the University of Colorado School of Pharmacy, discusses key points in the new guidelines for high cholesterol management.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$